Skip to main content
Medical information Clinical review pending

Genetic Testing

POLG Gene Neuropathy with Sensory Ataxic Dysarthria and Ophthalmoparesis Genetic Test

Genetic test using Next Generation Sequencing (NGS) to identify mutations in the POLG gene associated with specific neurological disorders like sensory ataxia, dysarthria, and ophthalmoparesis.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (usually collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.
Results
Confirm turnaround time with the laboratory before booking.
Preparation
Generally, no special preparation is required. However, confirm with the laboratory for any specific instructions.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the POLG Gene Neuropathy with Sensory Ataxic Dysarthria and Ophthalmoparesis Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Unexplained sensory ataxia
  • ✓Dysarthria (difficulty speaking)
  • ✓Ophthalmoplegia (eye movement disorders)
  • ✓Family history of related neurological disorders
  • ✓Suspected mitochondrial dysfunction
  • ✓Diagnosis of POLG-related neurological conditions
02

In plain language

What this test helps you understand

This test helps diagnose genetic mutations in the POLG gene, which are associated with specific neurological conditions characterized by sensory ataxia, dysarthria, and ophthalmoparesis. Identifying these mutations can aid in understanding the underlying cause of symptoms, guiding treatment decisions, and providing information for genetic counseling.
The POLG Gene Neuropathy with Sensory Ataxic Dysarthria and Ophthalmoparesis NGS Genetic DNA Test is a diagnostic tool using Next Generation Sequencing (NGS) technology. It identifies genetic mutations linked to neurological disorders. This test helps understand the causes of symptoms such as sensory ataxia (difficulty with coordination), dysarthria (slurred speech), and ophthalmoplegia (problems with eye movement), guiding effective management.

This test specifically looks for mutations in the POLG gene, which is important for mitochondrial function. Identifying these mutations can help diagnose conditions related to mitochondrial dysfunction, which can cause various neurological symptoms.

Individuals experiencing unexplained sensory ataxia, dysarthria, or ophthalmoplegia may benefit from this test. It is also recommended for those with a family history of similar neurological disorders or suspected genetic predispositions. Discussing your family history with a healthcare provider or genetic counselor is advised.

Benefits of this test include accurate diagnosis, guidance for treatment and management, informed family planning, and potential for early intervention. Results will indicate the presence of specific genetic mutations. A healthcare professional will help interpret the results and discuss implications and next steps.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationGenerally, no special preparation is required. However, confirm with the laboratory for any specific instructions.
SampleBlood sample (usually collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.
MethodologyNext Generation Sequencing (NGS) of the POLG gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes specific regions of the POLG gene. It may not detect all possible mutations, such as large deletions or duplications, or mutations in other genes that could cause similar symptoms. Results should be interpreted alongside clinical findings.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

The POLG gene provides instructions for making a protein essential for the function of mitochondria, the energy-producing parts of cells. Mutations in this gene can lead to various neurological disorders.
Individuals experiencing symptoms like sensory ataxia, dysarthria, or ophthalmoplegia, especially if unexplained or with a family history of similar conditions, should discuss this test with their doctor.
The test typically involves a blood sample. The laboratory uses Next Generation Sequencing (NGS) technology to analyze the POLG gene for specific mutations.
A healthcare professional will interpret the test results in the context of your medical history and symptoms. Genetic counseling may be recommended to discuss the implications of the findings.
Yes, genetic counseling is often recommended before and after testing to help understand the test, its implications, and the meaning of the results for you and your family.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp